AMS' Planned IPO Proceeds To Pay Down Debt, Complete Influence Payments
This article was originally published in The Gray Sheet
Executive Summary
A planned initial public offering by American Medical Systems Holdings, Inc., maker of urological disorder treatment devices, is anticipated to raise $68.8 mil. -including $40 mil. tabbed to "repay all of the outstanding debt under the guaranteed portion" of a $115 mil. credit facility.
You may also be interested in...
AMS Buys Influence, Inc. To Expand Incontinence Product Offerings
American Medical Systems is bulking up its sales force and expanding its urology product offerings through its planned acquisition of Influence, Inc. Terms of a Nov. 29 definitive merger agreement were not disclosed.
AMS Bulking Out Stress Incontinence Offerings Via UroVive Acquisition
American Medical Systems and UroSurge expect to complete by year-end a modular premarket approval application submission for the UroVive urethral bulking agent system. AMS agreed to acquire the product from UroSurge on July 26.
Howmedica Is Sole Remaining Pfizer Device Business Following AMS Sale
Pfizer's proposed $130 mil. sale of its American Medical Systems urological products business to the investment firm of E.M. Warburg, Pincus & Co., announced July 22, leaves the Howmedica orthopedics business the sole remaining unit of the Pfizer medical technology group.